<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Cryoport, Inc. — News on 6ix</title>
<link>https://6ix.com/company/cryoport-inc</link>
<description>Latest news and press releases for Cryoport, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 04 May 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/cryoport-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68355b8878dffbe2df0ebf05.webp</url>
<title>Cryoport, Inc.</title>
<link>https://6ix.com/company/cryoport-inc</link>
</image>
<item>
<title>Cryoport Reports First Quarter 2026 Financial Results</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-reports-first-quarter-2026-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-reports-first-quarter-2026-financial-results</guid>
<pubDate>Mon, 04 May 2026 20:05:00 GMT</pubDate>
<description>Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced financial results for its first quarter (Q1) of 2026.</description>
</item>
<item>
<title>Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-to-report-first-quarter-2026-financial-results-on-may-4-2026</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-to-report-first-quarter-2026-financial-results-on-may-4-2026</guid>
<pubDate>Mon, 20 Apr 2026 20:05:00 GMT</pubDate>
<description>Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced that the Company will report financial results for the first quarter ended March 31, 2026 on Monday, May 4, 2026 after U.S. markets close.</description>
</item>
<item>
<title>Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-reports-fourth-quarter-and-full-year-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-reports-fourth-quarter-and-full-year-2025-financial-results</guid>
<pubDate>Tue, 03 Mar 2026 21:05:00 GMT</pubDate>
<description>Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced financial results for its fourth quarter (Q4) and year ended (FY) December 31, 2025.</description>
</item>
<item>
<title>Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-report-fourth-quarter-full-130000144</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-report-fourth-quarter-full-130000144</guid>
<pubDate>Tue, 17 Feb 2026 13:00:00 GMT</pubDate>
<description>Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of temperature-controlled supply chain solutions for the life sciences, today announced that the Company will report financial results for the fourth quarter and year ended December 31, 2025 on Tuesday, March 3, 2026 after U.S. markets close.</description>
</item>
<item>
<title>Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoports-mve-biological-solutions-introduces-133000873</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoports-mve-biological-solutions-introduces-133000873</guid>
<pubDate>Wed, 11 Feb 2026 13:30:00 GMT</pubDate>
<description>Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of temperature-controlled supply chain solutions for the life sciences, today announced the launch of the MVE Fusion® 800 Series, the next evolution of MVE Biological Solutions' patented, award-winning Fusion technology. This self-sustaining cryogenic freezer eliminates the need for a continuous liquid nitrogen (LN₂) supply, delivering exceptional reliability, safety, and sustainability in a compact footprint</description>
</item>
<item>
<title>Cryoport Systems Wins 2025 BioTech Breakthrough Award For “BioServices Innovation of the Year”</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-systems-wins-2025-biotech-173000304</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-systems-wins-2025-biotech-173000304</guid>
<pubDate>Thu, 06 Nov 2025 17:30:00 GMT</pubDate>
<description>Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation Around the WorldLOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe, today announced that Cryoport Systems, a subsidiary of Cryoport, Inc. (Nasdaq: CYRX), a leader in temperature-controlled supply chain solutions for the</description>
</item>
<item>
<title>Cryoport Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-reports-third-quarter-2025-210500321</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-reports-third-quarter-2025-210500321</guid>
<pubDate>Tue, 04 Nov 2025 21:05:00 GMT</pubDate>
<description>Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of temperature-controlled supply chain solutions for the life sciences, today announced financial results for its third quarter (Q3) and first nine months (9M) of 2025. Provided in this press release are financial performance highlights, an update to our annual revenue guidance for 2025 and access information for today's earnings conference call.</description>
</item>
<item>
<title>Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-continues-set-benchmarks-global-123000065</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-continues-set-benchmarks-global-123000065</guid>
<pubDate>Thu, 30 Oct 2025 12:30:00 GMT</pubDate>
<description>Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in temperature-controlled supply chain solutions for the life sciences, today announced that Cryoport Systems, a Cryoport company, has successfully achieved certification under ISO 21973:2020, the international standard for transportation of human cells for therapeutic use published by the International Organization for Standardization (ISO). This milestone underscores Cryoport Systems' commitment to safety and traceabi</description>
</item>
<item>
<title>Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-report-third-quarter-2025-120000908</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-report-third-quarter-2025-120000908</guid>
<pubDate>Tue, 21 Oct 2025 12:00:00 GMT</pubDate>
<description>Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences, today announced that the Company will report financial results for the third quarter ended September 30, 2025 on Tuesday, November 4, 2025 after U.S. markets close.</description>
</item>
<item>
<title>MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars</title>
<link>https://6ix.com/company/cryoport-inc/news/mve-biological-solutions-cryoport-company-123000878</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/mve-biological-solutions-cryoport-company-123000878</guid>
<pubDate>Tue, 07 Oct 2025 12:30:00 GMT</pubDate>
<description>Cryoport, Inc. (NASDAQ: CYRX), a global leader in supply chain solutions for the life sciences, today announced the unveiling of MVE Biological Solutions' ("MVE") integrated Condition Monitoring Solutions for its MVE SC 4/2 V and 4/3 V series dewars, both powered by Tec4Med, another Cryoport company. This launch reflects MVE's commitment to support the life sciences with intelligent, connected assets to safeguard vital commodities.</description>
</item>
<item>
<title>Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-systems-expands-global-footprint-123000986</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-systems-expands-global-footprint-123000986</guid>
<pubDate>Wed, 01 Oct 2025 12:30:00 GMT</pubDate>
<description>Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in temperature-controlled supply chain solutions for the life sciences, today announced the launch of its newest, state-of-the art facility in Louvres, France, through its subsidiary, Cryoport Systems. The facility, which is strategically located near the Paris Charles de Gaulle Airport, marks a strategic expansion of Cryoport Systems' Global Supply Chain Center (GSCC) network, which offers end-to-end temperature-contro</description>
</item>
<item>
<title>Cryoport Reports Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-reports-second-quarter-2025-201900994</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-reports-second-quarter-2025-201900994</guid>
<pubDate>Tue, 05 Aug 2025 20:19:00 GMT</pubDate>
<description>Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of temperature-controlled supply chain solutions for the life sciences, today announced financial results for its second quarter (Q2) and first half (H1) of 2025.</description>
</item>
<item>
<title>Cryoport to Report Second Quarter 2025 Financial Results on August 5, 2025</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-report-second-quarter-2025-120000857</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-report-second-quarter-2025-120000857</guid>
<pubDate>Tue, 22 Jul 2025 12:00:00 GMT</pubDate>
<description>Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences, today announced that the Company will report financial results for the second quarter ended June 30, 2025 on Tuesday, August 5, 2025 after U.S. markets close.</description>
</item>
<item>
<title>Cryoport's MVE Biological Solutions Introduces Next Generation Vapor Shippers</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoports-mve-biological-solutions-introduces-120000144</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoports-mve-biological-solutions-introduces-120000144</guid>
<pubDate>Tue, 08 Jul 2025 12:00:00 GMT</pubDate>
<description>Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences, today announced the launch of MVE Biological Solutions' new vapor shippers, the SC 4/2V and SC 4/3V, offering medical and animal health professionals, laboratories, researchers, hospitals and clinics, pharmaceutical companies, and others dramatically improved safety and reliability for transporting and preserving sensitive biological materials at cryogenic temperatures.</description>
</item>
<item>
<title>Cryoport Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-completes-cryopdp-divestiture-commences-120000380</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-completes-cryopdp-divestiture-commences-120000380</guid>
<pubDate>Thu, 12 Jun 2025 12:00:00 GMT</pubDate>
<description>Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leader in temperature-controlled supply chain solutions for the Life Sciences, with a focus on regenerative medicine, today announced the completion of the previously disclosed divestiture of its specialty courier business, CRYOPDP, to DHL Group ("DHL"), one of the world's leading logistics providers, in a transaction that includes cash payments of approximately $200 million to Cryoport.</description>
</item>
<item>
<title>Cryoport Reports First Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-reports-first-quarter-2025-200500053</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-reports-first-quarter-2025-200500053</guid>
<pubDate>Wed, 07 May 2025 20:05:00 GMT</pubDate>
<description>Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global provider of temperature-controlled supply chain solutions for the life sciences sector, today announced financial results for the first quarter (Q1) ended March 31, 2025.</description>
</item>
<item>
<title>Cryoport to Report First Quarter 2025 Financial Results on May 7, 2025</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-report-first-quarter-2025-123000661</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-report-first-quarter-2025-123000661</guid>
<pubDate>Thu, 24 Apr 2025 12:30:00 GMT</pubDate>
<description>Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global provider of supply chain solutions for the life sciences sector, today announced that the Company will report financial results for the first quarter ended March 31, 2025 on Wednesday, May 7, 2025 after U.S. markets close.</description>
</item>
<item>
<title>Cryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ET</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-host-investor-call-discuss-120900047</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-host-investor-call-discuss-120900047</guid>
<pubDate>Mon, 31 Mar 2025 12:09:00 GMT</pubDate>
<description>Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences sector, today announced that the Company will host an investor call today, Monday, March 31, 2025, at 8:30 a.m. ET, to discuss the Company's recent strategic agreement and transformative transaction, which includes a strategic partnership with the DHL Group (DHL) and DHL's acquisition of CRYOPDP</description>
</item>
<item>
<title>Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoports-mve-biological-solutions-expands-123000159</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoports-mve-biological-solutions-expands-123000159</guid>
<pubDate>Wed, 12 Mar 2025 12:30:00 GMT</pubDate>
<description>Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today announced the launch of MVE Biological Solutions' ("MVE") High-Efficiency 800 C, the latest addition to its next-generation High-Efficiency ("HE") Series of cryogenic freezers. The HE 800 C combines ergonomic features and consistent performance in a compact size to meet the evolving needs of fertility clinics, biorepositories and clinical laboratories.</description>
</item>
<item>
<title>Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results</title>
<link>https://6ix.com/company/cryoport-inc/news/cryoport-reports-fourth-quarter-full-211000654</link>
<guid isPermaLink="true">https://6ix.com/company/cryoport-inc/news/cryoport-reports-fourth-quarter-full-211000654</guid>
<pubDate>Tue, 04 Mar 2025 21:10:00 GMT</pubDate>
<description>Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global leader in supply chain solutions for the life sciences industry, today announced financial results for the fourth quarter (Q4) and year ended (FY) December 31, 2024.</description>
</item>
</channel>
</rss>